| Source: |
| Type: |
| Cancer and inflammation are closely linked, with chronic inflammation contributing to the development and progression of cancer. Various inflammatory mediators and cells are involved in this process. |
| 6817- | EMD, | Emodin inhibits aggregation of amyloid-β peptide 1–42 and improves cognitive deficits in Alzheimer's disease transgenic mice |
| - | in-vivo, | AD, | NA |
| 6819- | EMD, | Recent advances in the therapeutic potential of emodin for human health |
| - | Review, | Nor, | NA |
| 6820- | EMD, | The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb—A Summary Update |
| - | Review, | Nor, | NA | - | Review, | Arthritis, | NA | - | Review, | AD, | NA |
| 6822- | EMD, | Behavioral, Histopathological, and Biochemical Implications of Aloe Emodin in Copper-Aβ-Induced Alzheimer's Disease-like Model Rats |
| - | in-vivo, | AD, | NA |
| 6823- | EMD, | Role of emodin to prevent gastrointestinal cancers: recent trends and future prospective |
| - | Review, | Var, | NA |
| 6826- | EMD, | Exploring the therapeutic potential of natural compounds for Alzheimer's disease: Mechanisms of action and pharmacological properties |
| 6827- | EMD, | Mechanism of Emodin in the Treatment of Rheumatoid Arthritis |
| - | Review, | Arthritis, | NA |
| 6829- | EMD, | Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug |
| 6833- | EMD, | Anticancer potential of emodin |
| - | Review, | Var, | NA |
| 6836- | EMD, | Emodin and the Anthraquinone Scaffold: Therapeutic Promise and Strategies to Overcome Translational Barriers |
| - | Review, | Nor, | NA |
| 5487- | EP, | High-frequency irreversible electroporation improves survival and immune cell infiltration in rodents with malignant gliomas |
| - | in-vivo, | GBM, | NA |
| 6800- | EPA, | DHA, | Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages |
| - | in-vitro, | Nor, | THP1 |
| 6798- | EPA, | Eicosapentaenoic acid attenuates cigarette smoke-induced lung inflammation by inhibiting ROS-sensitive inflammatory signaling |
| - | Human, | Nor, | NA |
| 6574- | EU, | Effects of Eurycoma longifolia Jack on chronic cerebral hypoperfusion-induced oxidative damage and memory deficit in rats |
| - | in-vivo, | Nor, | NA |
| 6584- | EU, | Eurycoma longifolia: an overview on the pharmacological properties for the treatment of common cancer |
| - | Review, | Var, | NA |
| 6772- | Eug, | Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint |
| - | Review, | Nor, | NA |
| 6355- | Eug, | Pharmacological and Toxicological Properties of Eugenol |
| - | Review, | Var, | NA |
| 6383- | Eug, | In Vitro Incorporation of Radioiodinated Eugenol on Adenocarcinoma Cell Lines (Caco2, MCF7, and PC3) |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Pca, | PC3 |
| 6381- | Eug, | Biological Properties and Prospects for the Application of Eugenol—A Review |
| - | Review, | Var, | NA |
| 6379- | Eug, | Safety assessment of a standardized polyphenolic extract of clove buds: Subchronic toxicity and mutagenicity studies |
| - | in-vivo, | Nor, | NA |
| 6377- | Eug, | Pharmacological Properties and Health Benefits of Eugenol: A Comprehensive Review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6376- | Eug, | Preparation, characterization, oral bioavailability, and pharmacodynamic study of eugenol-porous silica solidified powder |
| - | NA, | Nor, | NA |
| 6389- | Eug, | Molecular Insights into the Management of Eugenol's Anticancer Action Against Colon Cancer: A Detailed Review |
| - | Review, | Colon, | NA |
| 6386- | Eug, | A comprehensive and systematic review on potential anticancer activities of eugenol: From pre-clinical evidence to molecular mechanisms of action |
| - | Review, | Var, | NA |
| 6388- | Eug, | Eugenol’s anti-cancer properties, its modulation of signalling pathways, and cascades across various cancers: A review |
| - | Review, | Var, | NA |
| 6325- | Eug, | Anticancer Properties of Eugenol: A Review |
| - | Review, | Var, | NA |
| 6324- | Eug, | Pharmacodynamic, pharmacokinetic, toxicity, and recent advances in Eugenol's potential benefits against natural and chemical noxious agents: A mechanistic review |
| - | Review, | Var, | NA |
| 6323- | Eug, | Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA |
| 6848- | EVO, | Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa |
| - | Review, | Nor, | NA |
| 4070- | FA, | Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial |
| - | Trial, | AD, | NA |
| 3710- | FA, | Therapeutic Potential of Ferulic Acid in Alzheimer's Disease |
| - | Review, | AD, | NA |
| 3711- | FA, | A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease |
| - | Review, | AD, | NA |
| 3712- | FA, | Ferulic Acid: A Hope for Alzheimer’s Disease Therapy from Plants |
| - | Review, | AD, | NA |
| 3714- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review |
| - | Review, | AD, | NA |
| 3716- | FA, | Ferulic Acid as a Protective Antioxidant of Human Intestinal Epithelial Cells |
| - | in-vitro, | IBD, | NA | - | in-vivo, | NA, | NA |
| 3717- | FA, | Neuroprotective Properties of Ferulic Acid in Preclinical Models of Alzheimer's Disease: A Systematic Literature Review |
| - | Review, | AD, | NA |
| 3718- | FA, | Therapeutic potential of ferulic acid and its derivatives in Alzheimer's disease-A systematic review |
| - | Review, | AD, | NA |
| 3781- | FA, | Therapeutic potential of ferulic acid and its derivatives in Alzheimer’s disease—A systematic review |
| - | Review, | AD, | NA |
| 3779- | FA, | A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease |
| - | Review, | AD, | NA |
| 3778- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer’s Disease: A Narrative Review |
| - | Review, | AD, | NA |
| 6873- | FA, | Ferulic acid: extraction, estimation, bioactivity and applications for human health and food |
| - | Review, | Nor, | NA |
| 6877- | FA, | The protective role of ferulic acid on sepsis-induced oxidative damage in Wistar albino rats |
| - | in-vivo, | Nor, | NA |
| 6886- | FA, | MTX, | Ferulic acid prevents oxidative stress, inflammation, and liver injury via upregulation of Nrf2/HO-1 signaling in methotrexate-induced rats |
| - | in-vivo, | Nor, | NA |
| 6885- | FA, | Mitigation of renal toxicity induced by paraquat using ferulic acid: Role of inflammatory pathways |
| - | in-vivo, | Nor, | NA |
| - | Trial, | AD, | NA |
| 6954- | FA, | Folic acid as a potential therapeutic agent for Alzheimer's disease: Effects on inflammatory cytokines, amyloid deposition, and neurotransmitter metabolism |
| - | Trial, | AD, | NA |
| 1654- | FA, | Molecular mechanism of ferulic acid and its derivatives in tumor progression |
| - | Review, | Var, | NA |
| 6907- | FIS, | Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors |
| - | in-vitro, | AD, | NA |
| 6909- | FIS, | Modulation of PI3K/ AKT/ mTOR and apoptosis pathway in colon cancer cells by the plant flavonoid fisetin |
| - | in-vitro, | Colon, | Caco-2 |
| 6906- | FIS, | Rad, | Combining fisetin and ionizing radiation suppresses the growth of mammalian colorectal cancers in xenograft tumor models |
| - | in-vivo, | CRC, | CT26 | - | in-vivo, | CRC, | HCT116 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:953 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid